Johnson & Johnson faces allegations in a pair of suits filed March 30 that users of its popular diabetes drug, Invokana, develop kidney damage and heart disease.
April 01, 2016 at 01:40 PM
1 minute read
Johnson & Johnson faces allegations in a pair of suits filed March 30 that users of its popular diabetes drug, Invokana, develop kidney damage and heart disease.
The latest filings bring the number of Invokana suits filed in federal court in New Jersey to three. Another case making similar claims was filed in November 2015.
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
